Walled Lake Planning & Wealth Management »

Fs Global Cr Opportunitie Fda shares owned by Walled Lake Planning & Wealth Management

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Walled Lake Planning & Wealth Management from 13F filings

Historical chart of Walled Lake Planning & Wealth Management investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Walled Lake Planning & Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Walled Lake Planning & Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $105k 18k 5.93

More positions owned by Walled Lake Planning & Wealth Management

Doubleline Shiller CAPE US Equity Shiller Cape U S (CAPE)
iShares MSCI USA Min Vol Factor Msci Usa Min Vol (USMV)
Schwab US Dividend Equity ETF Us Dividend Eq (SCHD)
iShares MSCI USA Equal Weight Msci Equal Weite (EUSA)
Invesco S&P 500 Equal Weight Healthcare S&p500 Eql Hlt (RSPH)
Apple (AAPL)
iShares Russell 1000 Growth Rus 1000 Grw Etf (IWF)
Merck & Co (MRK)
Huntington Ingalls Inds (HII)
Ross Stores (ROST)
Lockheed Martin Corporation (LMT)
Invesco S&P 500 Equal Weight Technology S&p500 Eql Tec (RSPT)
Vanguard High Dividend ETF High Div Yld (VYM)
Juniper Networks (JNPR)
Gilead Sciences (GILD)

View all positions for Walled Lake Planning & Wealth Management

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Sit Investment Associates
Wagner Wealth Management
Cetera Investment Advisers
LPL Financial
Penserra Capital Management
Envestnet Asset Management
H D Vest Advisory Services
Advisor Group Holdings
Rockefeller Capital Management
Saba Capital Management
Morgan Stanley

View all funds holding Fs Global Cr Opportunitie Fda